确定马鲁宾作为治疗类风湿性关节炎的甲素C抑制剂
Fei-Long Zhou1,2, Yu Zhang2, Cui Chang2
1Medical School, Fuyang Normal University, Fuyang 236037, China.
Molecules (Basel, Switzerland)
|November 13, 2025
概括
马鲁是一种天然化合物,有效地抑制Cathepsin C (CTSC),这是炎症性疾病中的关键酶. 这种强大的CTSC抑制剂对治疗中性粒细胞相关的炎症状况充满希望.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 素C (CTSC) 对中性粒细胞血清蛋白酶 (NSP) 成熟和炎症过程至关重要.
- CTSC是炎症性疾病的重要治疗点.
研究的目的:
- 为了确定CTSC.的天然产品抑制剂.
- 在炎症疾病模型中评估马鲁宾的治疗潜力.
主要方法:
- 自然产品图书馆的大规模选.
- 在体外测试测量CTSC和NSP活性,细胞毒性,氧化释放以及细胞因子/化学因子水平.
- 分子对接以预测结合相互作用.
- 在生体内进行的炎症和关节炎小鼠模型研究.
主要成果:
- 马鲁宾被确定为一种具有较低细胞毒性强大的CTSC抑制剂 (nM范围).
- 马鲁宾降低了NSP活性,氧化的产生,并在体外调节了细胞因子/化学因子水平.
- 在体内研究表明,马鲁在降低血液和骨髓中CTSC和NSP活性方面具有有效性,与AZD7986.6相比.
- 马鲁宾在辅助剂诱导的关节炎模型中显示出治疗效果.
结论:
- 马鲁是一种有前途的天然产品抑制剂CTSC.
- 马鲁宾在与中性粒细胞相关的炎症性疾病中显示出治疗潜力.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
473
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
473
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
470
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
470